CHLOROPHYLLIPT

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT CHLOROPHYLLIPT

Composition:

Active ingredient: 1 ml of solution contains 10 mg of chlorophyllipt extract, thick (10.76:1) (extractant ethanol 93%);

Excipient: ethanol (96%).

Pharmaceutical form. Ethanol solution.

Main physicochemical properties: transparent green liquid.

*Pharmacotherapeutic group. Antiseptics and disinfectants. ATC code D08AX.

Pharmacological properties.

Pharmacodynamics.

The drug has antibacterial activity against staphylococci, including antibiotic-resistant strains.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications. Treatment of infections caused by antibiotic-resistant strains of staphylococci; burn disease, trophic and poorly healing limb ulcers, in complex therapy of postoperative, postpartum, and other septic conditions; in the treatment of intestinal staphylococcal dysbiosis and eradication of staphylococcal carriage, cervical erosion.

Contraindications. Hypersensitivity to chlorophyllipt or to any other component of the drug.

Interaction with other medicinal products and other forms of interaction. It should be noted that if hydrogen peroxide residues are present in the wound, chlorophyllipt will precipitate. Therefore, after wound irrigation with hydrogen peroxide, its residues should be removed using sterile 0.9% sodium chloride solution. Enhances the effect of antiseptic agents.

Instructions for use.

This medicinal product contains 1484 mg/dose of ethanol (alcohol). It is harmful for patients suffering from alcoholism. Caution should be exercised when administering to patients with liver diseases and in patients with epilepsy.

Use during pregnancy or breastfeeding. This medicine should not be used during pregnancy or breastfeeding.

Ability to affect reaction rate when driving or operating machinery. Since the medicine contains 96% ethanol, caution should be observed when driving or operating machinery.

Method of Administration and Dosage

For adults and children aged 12 years and older, the drug should be administered orally, topically, or as an enema. Children aged 12 years and older should use the drug only as prescribed by a physician.

The 1% alcoholic solution of Chlorophyllipt should be taken orally to treat intestinal carriage of staphylococci and for prevention of postoperative complications. Adults and children aged 12 years and older should take 5 ml of the 1% alcoholic solution diluted in 30 ml of water, three times daily, 40 minutes before meals. The duration of treatment is determined individually, depending on the efficacy of therapy and the severity of the disease.

For treatment of intestinal staphylococcal carriage, Chlorophyllipt can also be administered as an enema (20 ml of the 1% alcoholic solution diluted in 1 liter of water – this is the dose for one enema). The procedure should be performed once daily. Administer the enema every other day. The treatment course consists of 10 procedures.

For topical use (treatment of burns and trophic ulcers), the 1% alcoholic solution should be diluted with a 0.25% novocaine solution in a 1:5 ratio.

When treating cervical erosion, first dry all folds of the vaginal mucosa and the vaginal portion of the cervix with a tampon, then apply the 1% solution of Chlorophyllipt to lubricate the cervical canal. For vaginal douching, dilute 15 ml of the 1% alcoholic solution in 1 liter of water.

The duration of the treatment course depends on the course of the disease and is determined individually by the physician.

Children. The drug may be used in children aged 12 years and older only as prescribed by a physician.

Overdose. May result in increased severity of adverse reactions. Treatment: symptomatic.

Side effects.

Allergic reactions, including rash, itching, hyperemia, angioneurotic edema.

Shelf life. 5 years.

Storage conditions. Store at a temperature not exceeding 25 °C in the original packaging.

Keep out of reach of children.

Packaging. 100 ml in a bottle in a carton.

Prescription status. Prescription only.

Manufacturer.

Limited Liability Company "Experimental Plant "GNCLS".

LIMITED LIABILITY COMPANY "CORPORATION "ZDOROVIYA".

Location of manufacturer and its registered business address.

Ukraine, 61057, Kharkiv region, city of Kharkiv, Vorobiova Street, building 8.

(Limited Liability Company "Experimental Plant "GNCLS")

Ukraine, 61013, Kharkiv region, city of Kharkiv, Shevchenka Street, building 22.

(LIMITED LIABILITY COMPANY "CORPORATION "ZDOROVIYA")